These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2669756

  • 21. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
    Stümpel F, Hartmann H, Brandenburg D, Creutzfeldt W.
    Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
    [Abstract] [Full Text] [Related]

  • 22. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
    Schwartz GP, Burke GT, Chanley JD, Katsoyannis PG.
    Biochemistry; 1983 Sep 13; 22(19):4561-7. PubMed ID: 6354263
    [Abstract] [Full Text] [Related]

  • 23. In vitro and in vivo potency of insulin analogues designed for clinical use.
    Vølund A, Brange J, Drejer K, Jensen I, Markussen J, Ribel U, Sørensen AR, Schlichtkrull J.
    Diabet Med; 1991 Nov 13; 8(9):839-47. PubMed ID: 1663018
    [Abstract] [Full Text] [Related]

  • 24. Effect of insulin fragments on biological activity of insulin and desoctapeptide insulin. II. Enhanced binding and mechanism studies.
    Kikuchi K, Larner J, Freer RJ, Day AR.
    J Biol Chem; 1981 Sep 25; 256(18):9445-9. PubMed ID: 7026554
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Enhanced specific insulin binding and insulin action with C-terminal B-chain pentapeptide derived from insulin.
    Kikuchi K, Larner J, Freer R, Day AR.
    FEBS Lett; 1980 Sep 22; 119(1):161-4. PubMed ID: 6775976
    [No Abstract] [Full Text] [Related]

  • 31. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
    Nakagawa SH, Tager HS.
    J Biol Chem; 1986 Jun 05; 261(16):7332-41. PubMed ID: 3519607
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine.
    Du H, Shi J, Cui D, Zhang Y.
    Acta Biochim Biophys Sin (Shanghai); 2008 Feb 05; 40(2):133-9. PubMed ID: 18235975
    [Abstract] [Full Text] [Related]

  • 34. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin.
    Burke GT, Chanley JD, Okada Y, Cosmatos A, Ferderigos N, Katsoyannis PG.
    Biochemistry; 1980 Sep 30; 19(20):4547-56. PubMed ID: 7000179
    [Abstract] [Full Text] [Related]

  • 35. A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
    Schwartz GP, Burke GT, Katsoyannis PG.
    Proc Natl Acad Sci U S A; 1989 Jan 30; 86(2):458-61. PubMed ID: 2643113
    [Abstract] [Full Text] [Related]

  • 36. Effect of neonatal insulin treatment on adult receptor binding capacity in rats.
    Inczefi-Gonda A, Csaba G, Dobozy O.
    Horm Metab Res; 1982 Apr 30; 14(4):221-2. PubMed ID: 7044935
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Preparation of semisynthetic insulin analogues from bis(tert-butyloxycarbonyl)-desoctapeptide-insulin phenylhydrazide: importance of the aromatic region B24-B26.
    Riemen MW, Pon LA, Carpenter FH.
    Biochemistry; 1983 Mar 15; 22(6):1507-15. PubMed ID: 6340739
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.